SPAROBOPAN Project (Spanish Registry of Robotic Pancreatic Surgery)
Launched by HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE · Mar 21, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • robotic pancreatic resections
- • Asa I-III
- • Signed informed consent
- Exclusion Criteria:
- • Less than 18 years old.
- • ASA IV
About Hospital General Universitario De Alicante
The Hospital General Universitario de Alicante is a leading academic medical institution in Spain, dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, the hospital focuses on innovative therapies and treatments across various medical disciplines, aiming to enhance patient outcomes and contribute to the global body of scientific knowledge. With a commitment to ethical standards and rigorous methodologies, the hospital collaborates with multidisciplinary teams of healthcare professionals and researchers to facilitate groundbreaking clinical trials that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
